Kuwait has earned a new Guinness World Record for the longest distance between a patient and a surgeon.
The inaugural edition of FIBO Arabia, an international trade exhibition for the health, fitness and wellness industries, was officially opened on Wednesday (October 1) by Naif Al-Dosari, advisor to the Deputy Minister of Sports in the Kingdom, in Riyadh.
In a pioneering new report, the International Coalition for Sustainable Infrastructure (ICSI) has unveiled the blueprint for the safely scaled application of nature-positive engineering (NPE) in ports, offshore renewable energy and in coastal protection.
Al Ain Farms Group (AAFG) and Dubai-backed food innovation centre Food Tech Valley, have signed an agreement to develop a 260,000 sq.ft. logistics hub. The facility will help strengthen the UAE’s food security and accelerate fresher food distribution.
The GCC has a compelling opportunity to emerge as a major destination for climate-aligned foreign direct investment (FDI), said a report. Of the $1 trillion green FDI wave, Saudi Arabia, UAE and Oman attracted $24 billion worth of investment from 2020-24.
About 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks, says World Health Organization's (WHO) second Global hypertension report.
Forty-one UAE doctors were honoured for outstanding service and impact on patient care by Thumbay Healthcare at its surgical conference.
Innovo, an industry leader in construction and innovation, has signed a strategic partnership with Siemens, a leading technology company, to drive innovation, digital transformation, and sustainable growth across building technologies in the UAE.
Dividend Gate Capital (DGC) has joined hands with Abdulla Fouad Group and a consortium of strategic investors, to acquire a majority stake in Zahrat Al Amal Medical Group, a leading provider of healthcare services based in Saudi capital Riyadh.
Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a strategic commercialisation agreement with Bio-Thera Solutions for the exclusive rights to commercialise a proposed biosimilar to Cosentyx (secukinumab) across the Mena region.
